| Literature DB >> 29950843 |
Ramona Ritzmann1, Christina Stark2,3, Anne Krause4.
Abstract
The neurological disorder cerebral palsy (CP) is caused by unprogressive lesions of the immature brain and affects movement, posture, and the musculoskeletal system. Vibration therapy (VT) is increasingly used to reduce the signs and symptoms associated with this developmental disability. The purpose of this narrative review was systematically to appraise published research regarding acute and long-term effects of VT on functional, neuromuscular, and structural parameters. Systematic searches of three electronic databases identified 28 studies that fulfilled the inclusion criteria. Studies were analyzed to determine participant characteristics, VT-treatment protocols, effect on gross motor function (GMF), strength, gait, posture, mobility, spasticity, reflex excitability, muscle tone, mass, and bone strength within this population, and outcome measures used to evaluate effects. The results revealed that one acute session of VT reduces reflex excitability, spasticity, and coordination deficits. Subsequently, VT has a positive effect on the ability to move, manifested for GMF, strength, gait, and mobility in patients with CP. Effects persist up to 30 minutes after VT. Long-term effects of VT manifest as reduced muscle tone and spasticity occurring concomitantly with improved movement ability in regard to GMF, strength, gait, and mobility, as well as increased muscle mass and bone-mineral density. Posture control remained unaffected by VT. In conclusion, the acute and chronic application of VT as a nonpharmacological approach has the potential to ameliorate CP symptoms, achieving functional and structural adaptations associated with significant improvements in daily living. Even though further studies including adult populations validating the neuromuscular mechanisms underlying the aforementioned adaptations should be fostered, growing scientific evidence supports the effectiveness of VT in regard to supplementing conventional treatments (physiotherapy and drugs). Therefore, VT could reduce CP-associated physical disability and sensorimotor handicaps. Goals for patients and their caregivers referring to greater independence and improved safety may be achieved more easily and time efficiently.Entities:
Keywords: gait; muscle; neuromuscular; posture; reflex; spasticity
Year: 2018 PMID: 29950843 PMCID: PMC6018484 DOI: 10.2147/NDT.S152543
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1PRISMA flow diagram of findings.
Note: Step-by-step approach for study identification, screening, and eligibility procedures, and final number of articles included.
Abbreviations: PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; CP, cerebral palsy.
Study quality on the PEDro scale: long-term adaptations to vibration
| PEDro scale items | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Sum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ahlborg et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Camerota et al | ✓ | CR | ||||||||||
| el-Shamy | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8 | ||
| Gusso et al | ✓ | ✓ | 1 | |||||||||
| Ibrahim et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Ko et al | ✓ | ✓ | ✓ | ✓ | 4 | |||||||
| Lee and Chon | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 | |||
| Reyes et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8 | ||
| Ruck et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Semler et al | ✓ | CR | ||||||||||
| Stark et al | ✓ | ✓ | ✓ | ✓ | 3 | |||||||
| Stark et al | ✓ | ✓ | ✓ | ✓ | 3 | |||||||
| Stark et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 8 | ||
| Tupimai et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Unger et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| Myśliwiec et al | ✓ | ✓ | ✓ | ✓ | 3 | |||||||
| Wren et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 7 | |||
| Yabumoto et al | CR | |||||||||||
| Score per item/average score | 14 (15) | 11 (15) | 5 (15) | 10 (15) | 1 (15) | 0 (15) | 7 (10) | 11 (15) | 6 (15) | 10 (15) | 14 (15) | 4 |
Notes: Longitudinal experiments investigating the chronic effect of vibration therapy on neuromuscular and functional parameters, as well as muscle and bone tissue. The bottom line illustrates the relative number per PEDro item and the overall average score. Note that CRs were excluded from evaluation, as scaling and items are not applicable for these study designs. 1, Eligibility criteria and source of participants; 2, random allocation; 3, concealed allocation; 4, baseline comparability; 5, blinded participants; 6, blinded therapists; 7, blind assessors; 8, adequate follow-up; 9, intention-to-treat analysis; 10, between-group comparisons; 11, point estimates and variability. Item 1 does not contribute to the total score.
Abbreviation: CR, case report.
Long-term adaptations to vibration
| Study | Intervention (duration, training protocol, exercise, control group) | Vibration characteristics (frequency, amplitude, duration) | Subjects (n), age, classification | Outcome measures | Results: significant long-term effects |
|---|---|---|---|---|---|
| Ahlborg et al | 8 weeks, three times a week Ex: 5-minute warm-up, static standing with 50° in hips and knees on platform, progressive training program (11 levels of intensity), finished with short-muscle stretching Con: resistance training on leg press, same warm-up and stretching, three sets of 10–15 reps with 2-minute rest (progressive training program) | vWBV, 25–40 Hz, 4 mm, 6 minutes (rest included) | n=14 (Con 7), 21–41 years, diplegic, GMFCS: NA | Spasticity (MAS), isokinetic muscle strength, 6MWT, TUG, GMFM88 | ↓Spasticity in knee extensors of stronger leg, ↑concentric and eccentric work and peak torque in the weak leg at angle speed 90°/second. Both groups improved at 30°/second, no difference between groups, no change, no change, ↑dimensions D (standing) and E (walking) |
| Camerota et al | 3 consecutive days, one session/day, postmeasurement 1 month later | Sinusoidal rMV on triceps surae, 100 Hz, 0.3–0.5 mm, 3×10 minutes, 1-minute break | n=1, 5 years, tetraplegic, GMFCS: II | Spatiotemporal gait parameters, kinematic gait parameters | ↑Step length, ↓stance duration relative to length of gait cycle, ↑gait velocity, ↑gait symmetry, ↓pelvic tilt anteversion and hip flexion |
| el-Shamy | 3 months, five times a week Ex: static/dynamic (squats, lateral shifting, tilting) Con: proprioceptive training | sWBV, 12–18 Hz, 2–6 mm, 3×3 minutes | n=30 (Con 15), 8–12 years, diplegic, GMFCS I–III | Isokinetic muscle strength, balance (Biodex) | ↑Knee-extension peak torque, ↑postural stability |
| Gusso et al | 20 weeks, four times a week Ex: standing knees slightly flexed Con: no | sWBV, 12–20 Hz, amplitude NA, 1×1–3×3 minutes | n=40, 11.3–20.8 years, GMFCS II–III | 6MWT, pQCT BMD of total body, DXA BMC of total body, DXA lean (muscle) mass, chair-rise test, force plate | ↑6MWT, ↑BMD, ↑BMC, ↑muscle mass, ↓chair-rising time |
| Ibrahim et al | 12 weeks Ex: standing knees slightly flexed Con: 1-hour conventional PT | sWBV, 12–18 Hz, 2–6 mm, 3×3 minutes, 3-minute break (add-on to 1-hour conventional PT) | n=30 (Con 15), 8–12 years, diplegic, GMFCS: NA | Isometric strength, spasticity (MAS), 6MWT, balance, GMFM88 | ↑Isometric muscle strength of knee extensors, ↓spasticity of knee extensors in stronger leg, ↑6MWT, no change between groups in walking balance, ↑dimensions D (standing) and E (walking) |
| Ko et al | 3 weeks, twice a week Ex: standing knees flexed 30° Con: conventional PT | sWBV, 20–24 Hz, 1–2 mm, 3×3 minutes, 3-minute break (add-on to 30-minute conventional PT twice a week) | n=24 (Con 12), 7–12 years, diplegia, hemiplegia, GMFCS I–III | JPS (joint-position sense), balance, gait (2-D) | ↑Ankle JPS, no difference between groups, ↑gait speed and step width |
| Lee and Chon | 8 weeks, five times a week Ex: static upright with handle bars Con: stretching, massage, sensorimotor training | sWBV, 5–25 Hz, 1–9 mm, 6×3 minutes | n=30 (Con 15), 10±2.26 years, spastic diplegia or quadriplegia, GMFCS NA | Gait test (3-D), ultrasonography | ↑Gait speed, stride length, cycle time, ↑ankle dorsiflexion and plantar flexion, ↑muscle thickness musculus tibialis anterior and soleus, no change in gastrocnemii |
| Reyes et al | 6 months, 7 days/week Con: placebo, 60 Hz and 90 Hz (three groups) | FV on radius and femur, 60 or 90 Hz, 0.3 g, 5 minutes a day | n=61 (placebo 21, 60 Hz 22, 90 Hz 18), 6–9 years, first neuron and some second neuron and other diseases | DXA BMD, DXA BMC, dynamometric muscle-strength measure, GMFM, MFM (gross motor), Quality-of-life questionnaire (PedsQL) | ↑BMD at ultradistal radius for 60 Hz group, ↑BMC at ultradistal radius for 60 Hz and 90 Hz groups, ↑muscle-force upper limb for 60 Hz group, no change in lower limb, no change, ↑in daily activity item, no change for other items |
| Ruck et al | 6 months, five times a week Ex: static/tilt angle (35° vertical) Con: school PT program | sWBV, 13–18 Hz, 2–6 mm, 3×3 minutes | n=20 (Con 10), 6.2–12.3 years, GMFCS II–IV | 10 m gait test, GMFM88 dimensions D (standing) and E (walking), DXA BMC lumbar spine and distal femur | ↑Walking speed, no significant difference, no positive treatment effect on bone |
| Semler et al | 6 months, five times a week at home Ex: static/tilt angle 40° | sWBV, 13–18 Hz, 0–6 mm, 4×3 minutes | n=1, 5 years, GMFCS NA | Spasticity assessment, gait tests | ↓Spasticity, ↑walking ability, ↑walking distance, ↑ability to perform unassisted steps |
| Stark et al | 6 months, ten times a week at home Ex: individualized according to goal-setting combined with multimodal treatment concept | sWBV (with and without tilt table), 5–25 Hz, amplitude NA, 3×3 minutes | n=78, 9.76 years, spastic diplegia, GMFCS I–V | DXA BMC of whole body without head, DXA lean (muscle) mass, modified GMFM, muscle force and angle of verticalism | ↑Percentage changes for BMC, ↑percentage changes for muscle mass, ↑modified GMFM, ↑percentage changes for muscle force and angle of verticalism |
| Stark et al | 6 months, ten times a week at home Ex: individualized according to goal setting combined with a multimodal treatment concept | sWBV (with and without tilt table), 5–25 Hz, amplitude NA, 3×3 minutes | n=356, 8.6±4.2 years | GMFM66 and GMFM88 | ↑GMFM66 total score, ↑All GMFM-88 dimensions |
| Stark et al | 14 weeks, ten times a week at home Ex: standing (if possible in squatting), sitting and four-point position with hands on platform Con: treatment as usual | sWBV (with and without tilt table), 12 and 22 Hz, maximum 2.5 mm, 3×3 minutes | 24 (Con 12), 12–24 months, GMFCS II–IV | GMFM66, PEDI (motor function) | Training was safe, developmental motor changes were similar in both groups |
| Tupimai et al | 6 weeks, five times a week Ex: standing with handle bar if necessary | Oscillating WBV (Aiko), 20 Hz, 2 mm, 1×5 minutes, 1-minute break | n=12, 6–18 years, spastic, GMFCS I–III | Spasticity (MAS), FTSST, balance (PBS) | ↓Spasticity, ↓time in FTSST, ↑balance on the PBS |
| Unger et al | 4 weeks, twice a week in week 1, three times a week in week 2, four to five times a week in weeks 3 and 4 Ex: trunk-oriented (sit-up variation, hip and lumbar extensions, plank) Con: inactive – groups switched after 4 weeks | vWBV, 35–40 Hz, 2–4 mm, 8×30 seconds (progression 45 seconds and 60 seconds) | n=27, 6–13 years, spastic diplegic, GMFCS I–III | 1MWT, posture (2-D photographic), ultrasound resting abdominal thickness, number of sit-ups (strength) | ↑Distance walked, ↑upright posture, ↑resting thickness of all four abdominal muscles (transversus abdominis, obliquus internus, obliquus externus, rectus abdominis), ↑sit-ups executed in 1 minute |
| Myśliwiec et al | 4 weeks, three times a week | vWBV, 20 Hz, 2 mm, 2×1 minute, 10-minute break | n=3, 22–30 years, spastic quadriplegic, GMFCS NA | ROM | ↑ROM in knee joint, no change in hip joint |
| Wren et al | 6 months, daily at home Ex: standing not specified Con: standing without WBV, groups switched after 6 months | Micro-impact (Juvent), 30 Hz 0.3 g, 10 minutes | n=31, 6–12 years, spastic hemi-, di-, tri-, quadriplegia, GMFCS I–IV | CT vertebral CBD, cross-sectional area, CBD tibia and geometry, plantar flexor strength | ↑Cortical bone area and moments of inertia, no difference in CBD or muscle, no correlation between compliance and outcome, similar in all GMFCS levels, no differences between vibration and standing for any muscle or strength variables |
| Yabumot et al | 5 weeks, PT twice a week + WBV for standing Ex: standing | vWBV, 30 Hz, 1–3 mm | n=1, 8 years, spastic diplegic, GMFCS III | 5 m walk test, spasticity (MAS), GMFM88, ROM with MTS (Tardieu) | ↑Number of steps, no change in spasticity, ↑GMFM88 dimension C (sitting) and D (standing), trend for increased ROM after intervention |
Note: Chronic effects in response to VT.
Abbreviations: Ex, exercise; vWBV, vertical whole-body vibration; GMFCS, Gross Motor Function Classification System; 1MWT, 1-minute walking test; MAS, modified Ashworth Scale; 6MWT, 6-minute walking test; TUG, timed up and go; GMFM, Gross Motor Function Measure; rMV, repeated muscle vibration; sWBV, side-alternating whole-body vibration; Con, control; pQCT, peripheral quantitative computed tomography; BMD, bone-mineral density; DXA, dual-energy X-ray absorptiometry; BMC, bone-mineral content; PT, physiotherapy; FV, focal vibration; MFM, motor-function measure; PEDI, Pediatric Evaluation of Disability Inventory; WBV, whole-body vibration; FTSST, five-time sit-to-stand test; PBS, pediatric balance scale; 2-D, two dimensional; ROM, range of motion; CT, computed tomography; CBD, cancellous bone density; MTS, modified Tardieu Scale.
Study quality on the PEDro scale: acute adaptations to vibration
| PEDro scale items | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Sum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cannon et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Cheng et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 6 | ||||
| Dickin et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Eklund and Steen | ✓ | ✓ | ✓ | 3 | ||||||||
| Krause et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Leonard et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Park et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Singh et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Tardieu et al | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 5 | |||||
| Tupimai et al | ✓ | ✓ | ✓ | ✓ | ✓ | 4 | ||||||
| Score per item/average score | 9 (10) | 2 (10) | 0 (10) | 10 (10) | 3 (10) | 0 (10) | 1 (10) | 7 (10) | 10 (10) | 5 (10) | 9 (10) | 5 |
Notes: Ten cross-section studies investigating the acute effect of vibration therapy on neuromuscular and functional parameters. The bottom line illustrates the relative number per PEDro item and the overall average score. 1, Eligibility criteria and source of participants; 2, random allocation; 3, concealed allocation; 4, baseline comparability; 5, blinded participants; 6, blinded therapists; 7, blind assessors; 8, adequate follow-up; 9, intention-to-treat analysis; 10, between-group comparisons; 11, point estimates and variability. Item 1 does not contribute to the total score.
Acute adaptations to vibration
| Study | Vibration characteristics (frequency, amplitude, duration) | Subjects (n), age, classification | Outcome measures | Results: significant acute effects |
|---|---|---|---|---|
| Cannon et al | FV 119 Hz, 0.5 mm, 3 minutes | n=3 (one with CP), 1–3 years, grading of GMF | Head-erect behavior (observations), paraspinal muscle activity (TVR), frequency of seizures | ↑Duration of head erect behavior (during vibration), ↑paraspinal muscle activation (during vibration), no effects on number of seizures |
| Cheng et al | vWBV 20 Hz, 2 mm, 1 minute (5×) | n=16, 9.8±2.3 years, GMFCS I–III | Spasticity MAS, active and passive ROM (AJ and KJ), relaxation index (Wartenberg pendulum index), gait 6MWT, and functional mobility TUG | ↓Spasticity score, knee extensors (MAS), ↑active ROM, no effects on passive ROM, ↑relaxation index, ↑distance for 6MWT, ↓time required for TUG |
| Dickin et al | vWBV 30–50 Hz, 2 mm, 1 minute (5×) | n=8, 20–51 years, CP 5–8 | Passive and dynamic ROM (AJ and KJ), gait parameters (speed, cadence, step, stride length, step and stride time, AJ and KJ angles) | ↑Dynamic ROM (ankle), ↑walking speed, ↑stride length |
| Eklund and Steen | FV 100–200 Hz, 1.5 mm, 30 seconds (maximum 1–2 minutes) | n>200, <18 years | Hyper- and hypotonia, acts of voluntary motor control (observations) | ↑Voluntary power (agonist), ↓hypertonicity (antagonist), ↑normal patterns of movement (dystonic syndrome), ↑body image function, kinesthesia, ↑spontaneous movement of weak muscles, ↑voluntary motor control, eg, memory of motor acts, pronunciation, feeding pattern |
| Krause et al | sWBV 16–24 Hz, 1.5–3 mm, 1 minute | n=44, 4–22 years, GMFCS II–IV | Stretch reflex, voluntary muscle activation, muscle coordination, aROM (AJ and KJ) | ↓Muscle-spindle reflex amplitude, ↑voluntary muscle activation, ↑muscle coordination, aROM (KJ) |
| Leonard et al | FV 200 Hz, amplitude NA, 3 seconds (5–10×) | n=6 (six Con), 12–16 years | Spinal excitability (H-reflex), shank-muscle activity during dorsiflexion, plantar flexion, and vibration | ↑Reflex amplitude during dorsiflexion (antagonist), ↑reflex amplitude during plantar flexion (agonist), but less compared to Con, ↓H-reflex amplitude during vibration (agonist), but less inhibition compared to Con |
| Park et al | sWBV 20 Hz, 2 mm, 10 minutes (2×) | n=17, 3–14 years, GMFCS I–IV | Spasticity (MAS, MTS) of plantar flexors (AJ), persistency of results | ↓Spasticity score (MAS and MTS), persistent results at 1 hour (MAS) and 2 hours (MTS) |
| Singh et al | Micro-impact (Juvent) 30–37 Hz, amplitude NA, 30 seconds | n=18 (10 Con), 4–12 years, GMFCS I–III | local-high intensity vibration (HLV) signal to tibia and femur, correlation of spasticity (MAS), and vibratory transmission | CP: ↑HLV in tibia, ↓HLV in femur, negative correlation with MAS Con: ↑HLV in tibia, ↑HLV in femur |
| Tardieu et al | FV 70 Hz, 0.5 mm, 10 seconds (3×) | n=22 (18 Con), 8–15 years, GMFCS | Vibration illusion | ↑Kinesthesia: vibration predicts reliably muscle contraction and joint movement |
| Tupimai et al | Oscillating WBV 20 Hz, 2 mm, 1 minute (5×) | n=12, 6–18 years, GMFCS I–III | Spasticity (MAS), muscle strength (FTSST), balance (PBS) | ↓Spasticity score (MAS), ↓time (FTSST), no effect on balance control |
Note: Illustration of chronic effects in response to VT.
Abbreviations: FV, focal vibration; CP, cerebral palsy; TVR, tonic vibration reflex; vWBV, vertical whole-body vibration; GMFCS, Gross Motor Function Classification System; MAS, modified Ashworth Scale; ROM, range of motion; 6MWT, 6-minute walking test; TUG, timed up and go; sWBV, side-alternating whole-body vibration; Con, control; aROM, active ROM; AJ, ankle joint; KJ, knee joint; NA, not available; MTS, modified Tardieu Scale; WBV, whole-body vibration; FTSST, five times sit-to-stand test; PBS, pediatric balance scale.
Conclusive effects of vibration therapy
| Clustering of parameters | Acute adaptations: effects of VT after a single bout | Chronic adaptations: effects of VT after weeks and months of application |
|---|---|---|
| Spasticity, reflex activation, muscle tone, cocontraction of antagonists | Reduced spasticity in dorsal extensors, plantar flexors, | Reduced spasticity in dorsal extensors, plantar flexors, |
| Voluntary activation | Increased voluntary activation of ankle and knee muscles, | |
| Kinesthesia | Improved joint-position sense, | Improved segmental position sense in the ankle joint |
| GMFM, total score, particular dimensions, particular tasks | Increased movement speed, | Increased GMFM66 total score, |
| Strength, torque, work, force, power, particular tasks | Increase in voluntary muscle power in upper and lower extremities, | Increased concentric peak torque, |
| Gait, spatiotemporal characteristics, joint kinematics, complex locomotor movements | Increased gait speed | Increased gait speed |
| Posture control and balance | No effects of VT | No effects of VT, |
| Mobility | Increased active and passive range of motion in the ankle | Increased active and passive range of motion in the ankle, |
| Quality of life | Increased well-being | Increased daily activity |
| Muscle thickness, lean body mass | Increased muscle thickness of shank thigh muscles | |
| BMD, BMC | Increased BMD in vertebral bodies, |
Note: Note that table sums up positive effects of VT only, without considering insignificant study results manifesting no effects.
Abbreviations: VT, vibration therapy; GMFM, Gross Motor Function Measure; TUG, timed up and go; BMD, bone-mineral density; BMC, bone-mineral content.
Figure 2Overview of results.
Note: Overview of mechanisms underlying vibration therapy and resulting short- and long-term effects.